[1]
2026. In-silico molecular docking, ADME study of new azetidin-2-one derivatives having imidazole moiety targeting cyclooxygenase-2 Enzyme. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 5 (Jan. 2026), 992–1003. DOI:https://doi.org/10.32947/ajps.v25i5.1313.